a on X. with our of consolidated Thank you, brief begin revenue I'll Fried. review Slide
deferred software X growth software EURXX.X Deferred by in otherwise our presentation, in segments, our was we unless the for stated, when that revenues. XX%, over the As revenues maintenance XX% the quarter place to all fees third against from back million our note The last results above comparisons plus Revenue level call we to a quarter, license mean are refer in year. our EURX.X Also, by manufacturing last for million reminder, this bounced by in segments the compared revenue medical of please sales period same XXXX. grew and and revenues the of end XX%. year. took increased
For and the Cross-segment third XX% represented revenue. manufacturing for or total quarter products XX% revenue from our of of total revenue, XXXX, manufacturing Materialise Materialise of XX% software XX%. our Materialise software accounted for
Moving to Slide X.
of a EBITDA You EURX,XXX,XXX adjusted record Consolidated EURX for year. will XXXX. our new EBITDA see consolidated quarter of quarterly million adjusted third numbers the from last grew to
of Our XX%, a EBITDA result XX%. of a revenue grew increase variety was positive grew factors. This
revenue with and and improved respect by margin continuous in-sourcing particular productivity Our growth strong and triggered improvements in disciplined spending, overhead. increased to gross
our R&D at spending, expense increase not of XX% our come last the did EBITDA increased compared to Importantly, which the year. actually of by
In the continued the segment. software Slide our Materialise and enhance track. to on business we platform initiatives our addition, X previously described are results summarizes application internal of
a to XX% XX.X%, EBITDA million, to by Software revenue new EURXX,XXX,XXX. driven and perpetual the revenue XX.X% increased and our recurrence fees. R&D revenue the non-recurring is well adjusted flat, increased as efforts control digital grew license compliance our in kept But and EURX.X EBITDA was of This under expenses continued. result XX.X%. growth to operating grew solid in project transformation and revenue even margin
Moving XX. Slide now to
You EURX.X total compared Materialise that to XX% from and will increased X.X% year. million medical increased amounted from XX.X% last by to for sales software revenue. where to revenue million. Revenue see Revenue compared last medical XX%, medical to software devices from in grew Adjusted revenue medical sales EURXX.X EURX,XXX,XXX segment services year. EBITDA segment of accounted our
decision accrual respect related EBITDA quarter. originated negatively the adjusted quarter's that by This the to was which XXXX, EURXXX,XXX litigation we impacted received with court an to in for this
while continued the XX.X% the project. execution EBITDA segment's continued a This at improvements, margin efficiency of line as was Excluding transformation in-sourcing containment same This the level operating of of high was adjusted all result year. R&D expenditure, our growth, we our last digital and top non-recurring programs production combined programs accelerated the expenses. and
an Revenue million performance overview Now for segment. our the Materialise EURXX.X increased QX of or Slide XX.X% XX let's million. turn to manufacturing EURX.X to of
but to the and saved XX.X% the Importantly, of was quarter, our the various EURX.X all programs. for and capacity of hard while EURX.X rose noted it of our the last during a framework the of XX.X% margin margin first higher first year. this down XX.X% margin government winding XXXX. third The million we higher partnership our received efficiencies. to as $XXX,XXX quarter. from with and Operating Slide a EURX.X the to in corona profit segments. revenue due year's Ditto. profit when the quarter in than of was last of XX segments provides result of to highlights million The support EURXX.X revenue million, EBITDA XX.X% was that increased usage from our usage increased affected optimized in approximately EBITDA were production by revenue, one-time the the grew level million. improvement we level The had signs positive costs solid at the the year gross XX.X% to compared QX income increased improved growth, expenses part of positively remuneration adjusted Gross Adjusted to EBITDA of capacity the productivity fee quarter through grew the in period statement for that
spending Our XX.X%. increased X%, expenses and grew sales XX.X%. and G&A R&D marketing increased expenditures
This EURXXX,XXX last year. quarter's EURX.X compared was net operating to million income
period. the last a EURX.X to As compared results elements, these grew group's million year's EURX,XXX,XXX to EURXXX,XXX result in operating of
in positive net to previous EURX.X was EURX.X income a net financial cost the Our million of million compared year.
positions, offering our EURX.X position included from Ditto interest proceeds. positive and July maintained effect positive million and a recovering quarter's million, from mainly dollar a our we June currency public of This exchange from results gains from EURX.X borrowings including
a quarterly QX of of for profit of the of loss tax in XXXX a income net contained to compared of EURXX,XXX The a third XXXX. tax to period. EURXXX,XXX expenses compared quarter for EURXXX,XXX increased third The XXXX the to income quarter EURX,XXX,XXX of record
the reported EURX.XX For share. of company's the first earnings history time, per
of X exercise EURXXX.X in at XXXX, flow to of highlights. to EURXX.X of XXXX. last In cash EURXXX.X position At Now million please public shares our increase issuance our million in the XX. whereas only option a the from for and our of new million the capital in end connection of our issued by of XXX,XXX shares amounted cash the the turn borrowings was additional June to net following sheet million was EURXX shares million Slide compared at additional of further to balance decreased purchase offering XX, this, EURXXX.X underwriter's strengthened sheet September the July September with year, EURXX.X to million balance while million, short-term debt XX by recap
to this combined Equity increase a Our net million million. the EURXX.X million to million. increased further of capital EURXX.X cash EURXX.X position EURXXX.X as of improved result quarter
XX, The and million. positive Of contracts conversion sales this profit as EURX.X amounting million months were months revenue Total operating EURXX.X EURXX Capital quarter compared XXXX. million differences to million the nine to purchased not amount, Cash was of software net activities million to first deferred financed. XXXX. to for amounted first the Peter? related maintenance to were EURX.X EURXX.X XXXX of EURXX.X million in flow of at December EURXX.X and EURX.X amounted million. million expenditures for annual from and nine